Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of a Novel Compound Effective Against Juvenile, Adult, and Drug-Resistant Schistosoma Species

Pharmaceutics(2025)10.3390/pharmaceutics17101268Source: DataRank Database

Development of a Novel Compound Effective Against Juvenile, Adult, and Drug-Resistant Schistosoma Species is a research paper published in Pharmaceutics (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (15)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Alexander B. Taylor ORCID,Stanton F. McHardy ORCID,Michael D. Cameron ORCID,Philip T. LoVerde ORCID,Sevan N. Alwan ORCID

Live enrichment

PubMed:41155906 OpenAlex:https://openalex.org/W4414615517

NIH NIAID

Grant: 1R56AI180213-01A1

Institute for Integration of Medicine and Science (IIMS) at UT Health San Antonio by the National Center for Advancing Translational Sciences, National Institutes of Health

Grant: UM1 TR004538

Office of the Vice President for Research Internal Funding Programs

Grant: 174597-23092

NIH HHS

Grant: S10 OD030374

NIAID NIH HHS

Grant: R56 AI180213

NCI NIH HHS

Grant: P30 CA054174

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4923/17/10/1268/pdf?version=1759034386

publisherhttps://www.mdpi.com/1999-4923/17/10/1268/pdf?version=1759034386

publisherhttps://www.mdpi.com/1999-4923/17/10/1268/pdf

journalhttps://doi.org/10.3390/pharmaceutics17101268

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41155906

Fields of Study

Parasites and Host InteractionsParasite Biology and Host InteractionsHelminth infection and control

Keywords

OxamniquinePraziquantelTropical diseaseSchistosomiasisDrugNeglected tropical diseasesIn vivoDrug developmentToxicitySchistosomadrug discoverydrug resistance